Background {#Sec1}
==========

Type III polyketides are generally small molecules generated by Type III polyketide synthases (PKSs). These multifunctional ketosynthases typically utilise free CoA thioesters as substrates without the involvement of an acyl carrier protein (ACP), and frequently catalyse specific cyclization reactions found in aromatic and pyrone polyketides \[[@CR1], [@CR2]\]. The recent explosion in genome sequencing, combined with bioinformatic analysis, has led to the identification of numerous uncharacterized Type III PKS genes in plants, fungi and bacteria, including actinomycetes \[[@CR1], [@CR3]--[@CR6]\]. Bacterial Type III PKSs are attractive to study for a number of reasons: they are widely distributed, make a variety of structurally different products and, compared to Type I and Type II PKSs, relatively simple to manipulate genetically \[[@CR7]\]. Some Type III PKSs are solely responsible for product formation. For example, germicidin synthase (Gcs) and the 1,3,6,8-tetrahydroxynaphthalene (THN) (RppA) synthases, commonly found in *Streptomyces* spp., are the only enzymes required to produce germicidin and THN, respectively \[[@CR5], [@CR8], [@CR9]\]. THN can oxidise spontaneously to yield the red-brown pigment flaviolin, which is involved in bacterial melanin production, although a cytochrome P450 monooxygenase was reported to be involved in the conversion of THN to flaviolin in *Streptomyces antibioticus* \[[@CR6], [@CR10], [@CR11]\]. Some Type III PKS genes are organized in small operons, such as *srsABC* of *Streptomyces griseus* that produces alkylresorcinols \[[@CR12]\]. Such operons may also reside in complex gene clusters where they provide a specific precursor for the biosynthesis of more elaborate specialized metabolites; for example, the *dpgABCD* operon that synthesizes dihydroxyphenylacetic acid which is used as a precursor for vancomycin, balhimycin, teicoplanin and kendomycin biosynthesis in *Amycolatopsis orientalis* \[[@CR13]\], *A. balhimycina* \[[@CR14]\], *Actinoplanes teichomyceticus* \[[@CR15]\] and *Streptomyces violaceoruber* \[[@CR16]\], respectively.

Within the actinomycetes, *Streptomyces* species such as *Streptomyces lividans* TK24, *Streptomyces coelicolor, Streptomyces avermitilis* and *Streptomyces albus* J1074 \[[@CR17], [@CR18]\] have been used as surrogate hosts for the heterologous expression of gene clusters encoding specialized metabolites. *S. avermitilis*, the industrial producer of avermectin \[[@CR19], [@CR20]\], and *S. coelicolor*, for many years the model species for the study of the genetics and biology of actinomycetes \[[@CR21]\], have both been manipulated genetically to enhance the level of expression of heterologous gene clusters \[[@CR22]--[@CR25]\], and derivatives of each have been used to produce a range of different heterologous specialized metabolites \[[@CR23], [@CR24], [@CR26]--[@CR32]\]. In this work, we have further engineered *S. coelicolor* M1152 \[[@CR24]\], a derivative of strain M145 from which four of the known antibiotic biosynthetic gene clusters had been deleted and which contains a mutation (C1298T) in *rpoB* that increases the level of secondary metabolite production, by removing all of its native Type III PKS genes. Deletion of the resident Type III PKS genes could potentially increase precursor pool levels and prevent undesirable interference with biosynthesis encoded by heterologous Type III PKS genes.

Results and discussion {#Sec2}
======================

Type III PKS genes in *S. coelicolor* {#Sec3}
-------------------------------------

Analysis of the genome sequence of *S. coelicolor* M145 revealed three endogenous Type III PKS genes: *sco1206*, *sco7221* and *sco7671* \[[@CR33]\]. *sco1206* encodes RppA which synthesizes 1,3,6,8-tetrahydroxynaphthalene (THN), the intermediate involved in bacterial melanin biosynthesis, by the condensation of five malonyl CoA molecules \[[@CR8]\]. *sco1206* lies upstream of *sco1207* and *sco1208* (Fig. [1](#Fig1){ref-type="fig"}), which are homologues of the characterized cytochrome P450 genes *mel* \[[@CR6]\] and *momA* \[[@CR10]\] in *S. griseus* and *S. antibioticus*, respectively; in each of these species, the single P450 gene lies adjacent to a *rppA* homologue. *S. coelicolor* thus differs in possessing two tandemly arranged P450 genes 3′ of the Type III PKS gene, with all three genes apparently translationally coupled. MomA was predicted to play a role in the oxidation of THN to form flaviolin \[[@CR10]\], while Mel was thought to couple molecules of THN to generate hexahydroxyperylenequinone melanin \[[@CR6]\]. Since *S. coelicolor* is not known to produce any of these three molecules, this gene cluster may not be expressed under commonly used laboratory growth conditions. *sco7221* was shown to play a role in germicidin biosynthesis \[[@CR5], [@CR34]\] and its product thus designated as germicidin synthase (Gcs). Analysis of Sco7671 revealed closest homology to a family of mycobacterial Type III PKSs \[[@CR34]\]. *sco7671, sco7669* and *sco7670* are likely to form an operon (Fig. [1](#Fig1){ref-type="fig"}) organized in a similar fashion to *srsABC* of *S. griseus* (known to produce phenolic lipids, the alkylresorcinols) \[[@CR12]\]. Although the function, substrate specificity and the product profile of *sco7671* have been investigated in vitro \[[@CR34]\], the final product of the gene cluster has not been identified. To generate a clean host for the heterologous expression of Type III PKS gene clusters, we set out to delete *sco7221* (*gcs*), *sco7669*-*7670*-*7671* (the *srs* operon) and *sco1206*-*1207*-*1208* (the *rppA* operon) from *S. coelicolor* M1152 \[[@CR24]\].Fig. 1Genetic organisation of the three Type III PKS loci in *S. coelicolor. sco7221* (*gcs*), *sco1206*-*1207*-*1208* (*rppA* operon) and *sco7669*-*7670*-*7671* (*srs* operon) targeted for deletion are shown as *black arrows*. Flanking genes are shown in *grey* together with their putative functions

Deletion of the three native Type III PKS genes and operons of *S. coelicolor* M1152 {#Sec4}
------------------------------------------------------------------------------------

All three Type III PKS genes and operons were deleted from *S. coelicolor* M1152 by PCR targeting \[[@CR35], [@CR36]\] (Fig. [2](#Fig2){ref-type="fig"}; see reference 35 for a detailed description of PCR targeting). For two of the mutations (Δ*sco7221* and Δ*sco7669*-*7670*-*7671*), in-frame deletions were generated in a two-step process; in the first step, the entire gene or operon in the corresponding cosmid was replaced with an apramycin (Apr) resistance cassette in *Escherichia coli* and the mutant allele then introduced into *S. coelicolor* M1152 to create an Apr^R^-marked mutant; in the second step, the Apr^R^ cassette in the cosmid was eliminated in *E. coli* using FLP-recombinase to leave an 81 bp scar sequence which was then introduced into the Apr^R^-marked mutant, replacing the Apr^R^ cassette and creating an in-frame deletion mutant. Deletion of *gcs* (*sco7221*; 1122 bp) yielded M1314, which was then used for the in-frame deletion of the *srs* operon (*sco7669*-*7670*-*7671*; 2786 bp) to yield the double Type III PKS deletion mutant, M1316. Finally, the *rppA* operon (*sco1206*-*1207*-*1208*; 2859 bp) was removed from M1316 by replacement with the Apr^R^ cassette to yield the triple mutant M1317 (Fig. [2](#Fig2){ref-type="fig"}). Confirmation of the mutations in M1314, M1316 and M1317 was achieved by PCR amplification using primers flanking the deleted regions of the chromosome followed by DNA sequencing (data not shown). With the previous removal of four antibiotic biosynthetic gene clusters (to generate M1152), the resulting septuple mutant M1317 has lost approximately 178 kb of chromosomal DNA compared to the parental strain M145.Fig. 2Construction of Type III PKS deletion mutants of *S. coelicolor* M1152. Mutagenized cosmids introduced into each strain are indicated by their pIJ numbers

All three deletion mutants grew and sporulated in a manner that was indistinguishable from M1152 when cultures were grown on SFM agar (data not shown).

Validation of *S. coelicolor* M1317 as a host for the expression of Type III PKS genes {#Sec5}
--------------------------------------------------------------------------------------

The well-characterized germicidin synthase gene of *S. coelicolor* was chosen initially to validate the utility of M1317 as a host for the expression of Type III PKS genes. *gcs* (*sco7221*), which is capable of producing five congeners \[[@CR5]\], was inserted downstream of the constitutive *ermE*\* promoter in two bifunctional multi-copy vectors, pIJ86 and pIJ12477 (a derivative of pIJ86 conferring kanamycin resistance), to give pIJ86 + *sco7221* and pIJ12477 + *sco7221*, respectively. pIJ86 + *sco7221* and pIJ86 were then transferred by conjugation into M1152 to yield M1152/pIJ86 + *sco7221* and M1152/pIJ86, respectively, while pIJ12477 + *sco7221* and pIJ12477 were transferred similarly to M1317 to obtain M1317/pIJ12477 + *sco7221* and M1317/pIJ12477, respectively. Germicidin production was assessed by HPLC analysis of 5 days culture supernatants of all four strains (Fig. [3](#Fig3){ref-type="fig"}a), and the masses of the peaks corresponding to each germicidin congener \[[@CR5]\] confirmed by mass spectrometry. While no production was observed, as expected, in M1317/pIJ12477, peaks corresponding to most of the germicidin congeners were detected in culture supernatants from the other three strains, with total production levels in M1317/pIJ12477 + *sco7221* and M1152/pIJ86 + *sco7221* 10.7- and 7.8-fold higher than in M1152/pIJ86, presumably at least partly attributable to the multi-copy nature of the vectors; production in M1317/pIJ12477 + *sco7221* was 1.4-fold higher than in M1152/pIJ86 + *sco7221*, potentially reflecting increased precursor supply in the septuple deletion mutant. In each case, germicidin A and germicidin B7 were the major products (Fig. [3](#Fig3){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}).Fig. 3Germicidin production in derivatives of *S. coelicolor* M1152. **a** HPLC chromatogram and chemical structures of germicidin derivatives \[[@CR5]\]. Mass spectroscopy confirmed the production of the following five germicidin congeners: 1, \[M + H\]^+^ = 197 *m*/*z*; 2, \[M + H\]^+^ = 197 *m*/*z*; 3, \[M + H\]^+^ = 183 *m*/*z*; 4 \[M + H\]^+^ = 183 *m*/*z* and 5, \[M + H\]^+^ = 183 *m*/*z*. The HPLC profiles for M1152 and M1317 were indistinguishable from those for M1152/pIJ86 and M1317/pIJ12477, respectively (data not shown). **b** Germicidin A, germicidin B7, and total germicidin production per mg dry weight of mycelium. The histograms show the average values obtained from duplicate cultures with the two individual measurements (Table [1](#Tab1){ref-type="table"}) indicated by *bars*Table 1Relative levels of production of germicidins and flaviolin in engineered strainsStrainRelative production (mAU × 10^3^)/mg dry weightGermicidin AGermicidin B7Total germicidinsFlaviolinM1152/pIJ860.44 ± 0.020.42 ± 0.080.86 ± 0.10NoneM1317/pIJ12477NoneNoneNoneNoneM1152/pIJ86 + *sco7221*1.13 ± 0.145.58 ± 0.706.71 ± 0.84NDM1317/pIJ12477 + *sco7221*1.88 ± 0.037.32 ± 0.279.19 ± 0.30NDM1152/pIJ12477 + *sven5367*NDNDND1.72 ± 0.27M1317/pIJ12477 + *sven5367*NDNDND2.16 ± 0.05*ND* not determined

To evaluate the use of M1317 as a host for the heterologous expression of Type III PKS genes, the *rppA* homologue of *S.venezuelae* (*sven5367*) was cloned in pIJ12477 to yield pIJ12477 + *sven5367* which was introduced into M1152 and M1317 to produce M1152/pIJ12477 + *sven5367* and M1317/pIJ12477 + *sven5367*, respectively. Both strains produced a red-brownish pigment on IPM agar and in GYM liquid medium that was not observed in strains carrying the vectors alone (M1152/pIJ86 and M1317/pIJ12477) (Fig. [4](#Fig4){ref-type="fig"}). RppA initially generates 1,3,6,8-tetrahydroxynapthalene (THN) which is rapidly converted to flaviolin \[[@CR6], [@CR8]\]. Since we were unable to detect THN by chromatography, we instead quantified flaviolin production. The mass of the HPLC peak corresponding to flaviolin was confirmed by mass spectrometry \[[@CR37]\] (Fig. [5](#Fig5){ref-type="fig"}a). Flaviolin production was readily detected in both M1152/pIJ12477 + *sven5367* and M1317/pIJ12477 + *sven5367*, while none was detected in M1152/pIJ86 and M1317/pIJ12477 (Fig. [5](#Fig5){ref-type="fig"}b; Table [1](#Tab1){ref-type="table"}), thus establishing the utility of M1317 as a host for the heterologous expression of Type III PKS genes. Production in M1317/pIJ12477 + *sven5367* was 1.3-fold higher than in M1152/pIJ12477 + *sven5367*, again potentially reflecting increased precursor supply in the septuple deletion mutant. While some bacterial Type III PKSs, like plant chalcone and stilbene synthases \[[@CR7]\], are sufficient alone for final product formation (e.g. the germicidin synthase of *S. coelicolor* \[[@CR5]\] and the THN synthases of several *Streptomyces* species \[[@CR8], [@CR38], [@CR39]\]), some require a cytochrome P450 encoded by a neighbouring gene to convert the intermediate they produce into the final product, e.g. the THN synthase of *S. antibioticus* \[[@CR10]\]. Interestingly, while *rppA* of *S. venezuelae* lies adjacent to a gene encoding a cytochrome P450 that may be required for flaviolin biosynthesis in that strain, expression of *rppA* alone was all that was required for heterologous production of flaviolin in *S. coelicolor*. It is possible that in this strain THN is either oxidized spontaneously to flaviolin or oxidized by one of the remaining 18 P450 monooxygenases encoded by the *S. coelicolor* genome \[[@CR40]\].Fig. 4*Red-brown* pigment production after heterologous expression of the *rppA* homologue of *S. venezuelae* in *S. coelicolor* M1317/pIJ12477 + *sven5367* (**a**, **c**) compared to the same host containing the empty expression vector (M1317/pIJ12477) (**b**, **d**). **a**, **b** cultures grown in GYM liquid medium; **c**, **d** cultures grown on IPM agarFig. 5Flaviolin production in derivatives of *S. coelicolor* M1152. **a** HPLC chromatogram of flaviolin (F) production in M1152/pIJ12477 + *sven5367* and M1317/pIJ12477 + *sven5367*; in each case, a mass of \[M + H\]^−^ 205 *m/z* was confirmed by mass spectrometry (data for M1317/pIJ12477 + *sven5367* is shown in the *inset*). GA and GB7 indicate peaks of germicidin A and germicidin B7, respectively. The HPLC profiles for M1152 and M1317 were indistinguishable from those for M1152/pIJ86 and M1317/pIJ12477, respectively (data not shown). **b** Flaviolin production per mg dry biomass weight. The histograms show the average values obtained from duplicate cultures with the two individual measurements (Table [1](#Tab1){ref-type="table"}) indicated by the *bars*

Our inability to detect flaviolin production in M1152/pIJ86 is consistent with previous work that also suggested that *sco1206* is not expressed in *S. coelicolor* under standard laboratory conditions \[[@CR8]\]. However, when the *rppA* operon of *S. coelicolor* (*sco1206*-*1207*-*1208*) expressed from the *ermE*\* promoter was introduced into M1317 to yield M1317/pIJ12477 + *sco1206*-*1207*-*1208*, red-brown pigment production occurred in both liquid- and agar-grown cultures. Flaviolin production in M1317/pIJ12477 + *sco1206*-*1207*-*1208* was confirmed by HPLC analysis and mass spectrometry (data not shown).

Conclusions {#Sec6}
===========

We have successfully engineered the expression host *S. coelicolor* M1152 by removing all three of the endogenous Type III PKS gene and operons, and validated the resulting septuple deletion M1317 as a host for the ectopic and heterologous expression of Type III PKS genes. We believe that *S. coelicolor* M1317 will prove to be a useful strain for the future analysis of Type III PKS genes and their products from a wide range of actinomycetes.

Methods {#Sec7}
=======

Bacterial strains, plasmids, cosmids and culture conditions {#Sec8}
-----------------------------------------------------------

Bacterial strains, plasmids and cosmids used and generated in this study are listed in Table [2](#Tab2){ref-type="table"}. *Escherichia coli* strains were grown and manipulated following standard methods \[[@CR35], [@CR36], [@CR41]\]. Media for the growth of *S. coelicolor* strains were: instant potato mash (IPM) agar \[[@CR42]\], SFM agar \[[@CR43]\], tryptic soy broth (TSB) and glucose-yeast extract-malt extract (GYM) medium \[[@CR44]\]. Liquid cultures of *Streptomyces* strains were performed in 50 ml of medium in 250 ml flasks containing stainless steel springs at 30 °C with shaking at 250 rpm. The following antibiotics were used when required: 50 µg/ml apramycin (Apr), 50 µg/ml kanamycin (Kan), 50 µg/ml hygromycin (Hyg) and 25 µg/ml nalidixic acid (Nal). An overnight culture of each *Streptomyces* strain was used to inoculate 50 ml of medium to give an initial OD~600~ nm = 0.1.Table 2Bacterial strains, plasmids and cosmids used and generated in this studyStrain/plasmid/cosmidDescriptionSource of referenceStrain *E. coli* BT340DH5α/pCP20\[[@CR45]\] *E. coli* BW25113K-12 derivative: Δ*araBAD*, Δ*rhaBAD*\[[@CR46]\] *E. coli* DH5αFor cloning and propagation of host strain, *deoR recA1 endA1 hsdR17*(*rk*-*, mk* ^+^) *phoA supE44 thi*-*1 gyrA96 relA1 λ* ^−^Invitrogen, USA *E. coli* ET12567*dam*-*13::Tn9* *dcm*-*6* *hsdM* *hsdS*\[[@CR47]\] *S. coelicolor* M1152Derivative of *S. coelicolor* M145, Δ*act* Δ*red* Δ*cpk* Δ*cda* *rpoB*(C1298T)\[[@CR28]\] *S. coelicolor* M1314*S. coelicolor* M1152 Δ*sco7221*This study *S. coelicolor* M1316*S. coelicolor* M1152 Δ*sco7221* Δ*sco7669*-*7670*-*7671*This study *S. coelicolor* M1317*S. coelicolor* M1152 Δ*sco7221* Δ*sco7669*-*7670*-*7671* Δ*sco1206*-*1207*-*1208*::(*oriT*-*aac(3)IV*)This studyPlasmid pGEM^®^-T Easy*E. coli* vector for cloning PCR product, amp^r^Promega, USA pIJ86*ermE*p\*, *aac(3)IV*, *oriT* (RK2), *ori* (pIJ101)*, ori* (pUC18)\[[@CR48]\] pIJ773pBluescript KS (+), *aac*(*3*)*IV*, *oriT* (RK2), FRT sites\[[@CR35]\] pIJ790λ-RED (*gam*, *bet*, *exo*), *cat*, *araC*, *rep101* ^ts^\[[@CR35]\] pIJ10701pBluescript KS (+), *hyg*, *oriT* (RK2), *bla*\[[@CR35]\] pIJ12477pIJ86, *neo*\[[@CR49]\] pIJ13000St2H12 ∆*sco7221*::(*oriT*-*aac*(*3*)*IV*)This study pIJ13001St4C2 ∆*sco7669*-*7670*-*7671*::(*oriT*-*aac*(*3*)*IV*)This study pIJ130022StG58 ∆*sco1206*-*1207*-*120*8::(*oriT*-*aac*(*3*)*IV*)This study pIJ13003St2H12 ∆*sco7221*This study pIJ13004pIJ13003::(*oriT*-*hyg*)This study pIJ13005St4C2 ∆*sco7669*-*7606*-*7671*This study pIJ13006pIJ13005::(*oriT*-*hyg*)This study pIJ130072StG58 ∆*sco1206*-*1207*-*1208*This study pIJ13008pIJ13007::(*oriT*-*hyg*)This study pUZ8002Kan^r^ */tra, neo, RP4*\[[@CR50]\]Cosmid 2StG58SuperCos1 containing *sco1206*-*1207*-*1208*John Innes Centre, UK St2H12SuperCos1 containing *sco7221*John Innes Centre, UK St4C2SuperCos1 containing *sco7669*-*7670*-*7671*John Innes Centre, UK Sv3G11SuperCos1 containing *sven5367*John Innes Centre, UK SuperCos1*neo*, *bla*Agilent Technology, USA

DNA manipulations for *E. coli* and *Streptomyces* {#Sec9}
--------------------------------------------------

Extraction of DNA from *E. coli* was carried out using standard methods \[[@CR36]\] or by using a QIAprep Spin Miniprep Kit (QIAGEN) and following the manufacturer's instructions. Genomic DNA was isolated from *Streptomyces* strains using the modified Kirby Mix procedure \[[@CR43]\]. PCR amplifications for confirmation of engineered cosmids, mutant strains and expression constructs were performed using *Taq* DNA polymerase (QIAGEN). Expand High Fidelity PCR System (Roche) was used to amplify disruption cassettes \[[@CR35]\] and Phusion^®^ High-Fidelity DNA Polymerase (NEB) was used to amplify PCR products for gene expression.

Deletion of the Type III PKS genes of *S. coelicolor* {#Sec10}
-----------------------------------------------------

The three native Type III PKS genes and operons of *S. coelicolor* (*sco7221*, *sco7669*-*7670*-*7671* and *sco1206*-*1207*-*1208*) were deleted from strain M1152 \[[@CR24]\] by PCR targeting \[[@CR35], [@CR41]\]. Three pairs of flanking primers, SCO7221FSpe and SCO7221RNhe, SCO7671FSpe and SCO7669RNhe, and SCO1206FSpe and SCO1208RNhe (Table [3](#Tab3){ref-type="table"}), were designed to amplify a 1458 bp fragment carrying an apramycin resistance (Apr^R^) *oriT* cassette from pIJ773 \[[@CR35]\]. Each of the Apr^R^ cassettes were flanked by 39 nt sequences matching the ends of the gene or operon to be deleted, and the targeted regions replaced with the Apr^R^ cassette by homologous recombination between these 39 nt sequences. Cosmids St2H12, St4C2 and 2StG58, containing *sco7221*, *sco7669*-*7670*-*7671* and *sco1206*-*1207*-*1208*, respectively, were transferred into *E. coli* BW25113 \[[@CR47]\]/pIJ790 \[[@CR35]\] and the resulting strains were then transformed with the corresponding replacement cassette. The mutagenized cosmids pIJ13000, pIJ13001 and pIJ13002, respectively, were verified by restriction enzyme digestion and PCR amplification with primers SCO7221TF and SCO7221TR, SCO7671TF and SCO7669TR, and SCO1206TF and SCO1208TR, respectively (Table [3](#Tab3){ref-type="table"}). pIJ13000 (∆*sco7221*::(*oriT*-*aac*(*3*)*IV*)) was then introduced into *S. coelicolor* M1152 by conjugation with selection for apramycin resistance; subsequent screening for loss of kanamycin resistance (encoded by the SuperCos 1 vector) but retention of apramycin resistance was used to isolate the required ∆*sco7221*::(*oriT*-*aac*(*3*)*IV*) replacement mutant. In the meantime, the Apr^R^ cassettes were removed from pIJ13000, pIJ13001 and pIJ13002 in *E. coli* BT340 \[[@CR46]\] using the FLP-recombinase, in each case leaving a 81 bp scar sequence in place of the cassette. The resulting non-transmissible cosmids, pIJ13003, pIJ13005 and pIJ13007, respectively, were confirmed by restriction enzyme digestion and PCR amplification using the same primer sets that were used for verification of the Apr^R^ cassettes (Table [3](#Tab3){ref-type="table"}). To allow transfer of these cosmids from *E. coli* to *Streptomyces* via conjugation, a *bla*-*oriT*-*hyg*-*bla* cassette was amplified from pIJ10701 \[[@CR35]\] and used to target the *bla* gene in the SuperCos1 backbone of pIJ13003, pIJ3005 and pIJ13007, yielding pIJ13004, pIJ13006 and pIJ13008, respectively. Intergeneric conjugation between the *S. coelicolor* ∆*sco7221*::(*oriT*-*aac*(*3*)*IV*) replacement mutant and *E. coli* ET12567/pUZ8002 \[[@CR47], [@CR50]\] containing pIJ13004 was performed as previously described \[[@CR35], [@CR41]\]. Exconjugants were selected based on hygromycin resistance and the desired ∆*sco7221* in-frame deletion mutant M1314 obtained by screening for Apr, Kan and Hyg sensitive segregants and confirmed by sequencing of the PCR product obtained from genomic DNA using primers SCO7221TF and SCO7221TR. Essentially the same procedure was used to generate the double in-frame deletion mutant M1316 (Δ*sco7221*, Δ*sco7669*-*7671*) from M1314 using pIJ13001 and pIJ13006 (and confirmed by sequencing the PCR amplicon obtained from genomic DNA using PCR primers SCO7671TF and SCO7669TR). Similarly the triple deletion mutant M1317 (Δ*sco7221*, Δ*sco7669*-*7671*, Δ*sco1206*-*1208*::*aac*(*3*)*IV*) was derived from M1316 using pIJ13002. Despite repeated attempts, it was not possible to remove the Apr^R^ cassette from M1317 using pIJ13008. Therefore, M1317 was confirmed by sequencing of the PCR product obtained from genomic DNA using PCR primers SCO1206TF and SCO1208TR. In each case the PCR fragment was cloned into pGEM^®^-T Easy and sequenced using M13 universal primers to verify that the expected deletions had been made.Table 3Primers used in this studyPrimerSequence 5′--3′DescriptionpIJ86F1ACGCCTGGTCGATGTCGGACSequencing primers for recombinant plasmids of pIJ86 and pIJ12477pIJ86R2TGCGGTCAGTGCGTGTGTCGSCO1206F1ATCCCCAAGACCGAGGACTGSequencing primer for internal sequence of *sco1206*-*1207*-*1208*SCO1206F2AGGCCGTCATGGACCGCCAGSCO1206F3TGTTCCACCTGCTGCTGAGCSCO1206F4AGTGGTGAGCGGCCTGGTCSCO1206FBglIIAAAAA**AGATCT**CGCAAGCCTTCCGCGAGGCGPCR of *sco1206*-*1207*-*1208* for cloning into pIJ12477SCO1208RHindIIIAAAAA**AAGCTT**CTAACCGTGTCGCAGCGGCGTGAGSCO1206FSpeCGCAAGCCTTCCGCGAGGCGAAAGCAGGCACGGTTCATG**ACTAGT**ATTCCGGGGATCCGTCGACCFlanking primers for *sco1206*-*1207*-*1208* disruption cassetteSCO1208RNheGATCGCGCGGACGCTGGCCGGGATGCCGATCCGCTAACC**GCTAGC**TGTAGGCTGGAGCTGCTTCSCO1206TFTCGAGCTGGCCAAGCTGTest primers for verification of Apr^R^ cassette replacements and in-frame deleted regionsSCO1208TRTGGAGTACGCGCAGACCSCO7221TFAGTTGCATGGGTCACTGCSCO7221TRATGTACCGGCCCAGAGCSCO7671TFGTTGCACCAGCCGATGGSCO7669TRGTGAGTCGATGACTGTCGTGGSCO7221F1AGTCGGTGCTCCGGCTGGACSequencing primer for internal sequence of *sco7221*SCO7221FBamHIAAAAA**GGATCC**CCTCACCTGCTCCGCAGCAGACCCPCR of *sco7221* for cloning into pIJ86 and pIJ12477SCO7221RHindIIIAAAAA**AAGCTT**CTACAGCCACTCCCCTTCCAGAGCGGTGGSCO7221FSpeCGCCGTGATACACGGCGAGCACTCCGTCGAGACCCGAGA**ACTAGT**ATTCCGGGGATCCGTCGACCFlanking primers for *sco7221* disruption cassetteSCO7221RNheGTGGCGGTCAGGCCCGGGGCCGCCGCGTACAGGACGGCA**GCTAGC**TGTAGGCTGGAGCTGCTTCSCO7671FSpeGTACGCACGGTAGTGGGGCCGGCGGCCGAGGAAGGCATG**ACTAGT**ATTCCGGGGATCCGTCGACCFlanking primers for *sco7669*-*7670*-*7671* disruption cassetteSCO7669RNheGTCCGCTACGCGCGCGCCGCGCGGGGCCGGAACGGCTCA**GCTAGC**TGTAGGCTGGAGCTGCTTCSVEN5367F1GGCCCGACACCGAGGACTGSequencing primer for internal sequence of *sven5367*SVEN5367FBamHIAAAAA**GGATCC**CGGGTGAGTGTGGGCGGCAGTTCPCR of *sven5367* for cloning into pIJ12477SVEN5367RHindIIIAAAAA**AAGCTT**TCAGGCGACGGACGTGCGGGBolds indicate restriction sites

The three mutants were grown on SFM agar until sporulation. Spores were harvested and stored in 20 % glycerol at −20 °C.

Construction of the type III PKS expression strains {#Sec11}
---------------------------------------------------

*sco7221* (*gcs*) and *sco1206*-*sco1207*-*sco1208* (*rppA* operon) from *S. coelicolor* and *sven5367* (*rppA* homologue) from *S. venezuelae* were amplified from cosmids St2H12, 2StG58 and Sv3G11, respectively, using primers SCO7221FBamHI and SCO7221RHindIII, SCO1206FBglII and SCO1206RHindIII, and SVEN5367FBamHI and SVEN5367RHindIII, respectively (Table [3](#Tab3){ref-type="table"}). The forward (F) primers were designed to include the ribosome binding sites of *sco7221*, *sco1206* and *sven5367*, respectively. The PCR products were cloned into pGEM^®^-T Easy and confirmed by restriction enzyme digestion and DNA sequencing using M13 universal primers and the internal primers SCO7221F1 for pGEM-T/*sco7221*, SCO1206F1, SCO1206F2, SCO1206F3 and SCO1206F4 for pGEM-T/*sco1206*-*sco1207*-*sco1208*, and SVEN5367F1 for pGEM-T/*sven5367* (Table [3](#Tab3){ref-type="table"}). Two multi-copy expression vectors, each containing the constitutive *ermE*\* promoter, were used; pIJ86 \[[@CR48]\] was employed in M1152, while pIJ12477 \[[@CR49]\] (a derivative of pIJ86 also conferring kanamycin resistance) was used in M1152 and in M1317. *sco7221* was sub-cloned as a *Bam*HI--*Hin*dIII fragment into both pIJ86 and pIJ12477, yielding pIJ86 + *sco7221* and pIJ12477 + *sco7221*, respectively. *sco1206*-*sco1207*-*sco1208* (*rppA* operon) were sub-cloned as a *Bgl*II--*Hind*III fragment into *Bam*HI plus *Hind*III cleaved pIJ12477, yielding pIJ12477 + *sco1206*-*sco1207*-*sco1208*. *sven5367* was sub-cloned as a *Bam*HI--*Hin*dIII fragment into pIJ12477 to obtain pIJ12477 + *sven5367*. Primers pIJ86F1 and pIJ86R2 (Table [3](#Tab3){ref-type="table"}), which anneal 220 and 229 bp from the *Bam*HI and *Hind*III cloning sites, respectively, were used to verify the recombinant plasmids by PCR amplification and sequencing in addition to restriction enzyme digestion. For pIJ12477 + *sco1206*-*sco1207*-*sco1208*, primers pIJ86F1 and the internal primers SCO1206F1, SCO1206F2, SCO1206F3 and SCO1206F4 were also used for sequencing. The plasmids were then introduced into *E. coli* ET12567/pUZ8002 by transformation and transferred to the appropriate *Streptomyces* host by conjugation as described previously \[[@CR43]\]. Exconjugants were selected on SFM agar containing 50 µg/ml apramycin or 50 µg/ml kanamycin as appropriate and 25 µg/ml nalidixic acid. Spore stocks were prepared on SFM agar containing the appropriate antibiotic for plasmid selection and stored in 20 % glycerol at −20 °C.

Analysis of germicidin and flaviolin production {#Sec12}
-----------------------------------------------

Cultures were grown for 5 days in 50 ml of GYM liquid medium, 5 ml of each culture supernatant lyophilized, the dried samples dissolved in 500 µl water and filtered through a VectaSpin Micro Polysulphone 0.2 µm column (Whatman). The samples were injected onto a Phenomenex Gemini-NX3u C18 110A, 150 × 4.6 mm column fitted to an Agilent 1100 HPLC system and analyzed using a linear methanol:water gradient in 0.1 % (w/v) formic acid as follows: 0 min, 10 % methanol; 1 min, 25 % methanol; 21 min, 100 % methanol; 25.50 min, 10 % methanol; 33 min, 10 % methanol, at a flow rate of 0.8 ml/min with UV absorbance monitoring at 280 nm. Fractions of interest were collected and analyzed by mass spectrometry (Thermo Scientific™). Germicidins were analyzed using positive ion mode mass spectrometry whereas flaviolin was analyzed using negative ion mode. Each experiment was carried out in duplicate. The mycelium from each 50 ml culture was harvested by centrifugation, dried and the dry weight determined. Relative levels of germicidin and flaviolin production were calculated by multiplying the average peak area (mAU) obtained from a 5 ml sample by ten and dividing by the average dry weight obtained from a 50 ml culture.

ACP

:   acyl carrier protein

Apr

:   apramycin

Gcs

:   germicidin synthase

Hyg

:   hygromycin

Kan

:   kanamycin

PKS

:   polyketide synthase

THN

:   1,3,6,8-tetrahydroxynaphthalene
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